SRA's number for the day: 19
This article was originally published in SRA
Executive Summary
A total of 19 pharmaceutical companies between 2009 and 2012 failed to submit one or more annual reports on deferred measures relating to paediatric investigation plans (PIPs) for authorized medicines, as required by the EU Paediatric Regulation1.